The hepatitis E virus cannot infect mice due to specific molecular barriers in murine cells, according to a virology study published by researchers investigating cross-species pathogen transmission. Understanding why certain animal models remain naturally resistant to human pathogens helps virologists map viral entry mechanisms and design better laboratory testing models for infectious diseases.
Cellular Restrictions in Murine Models
Infecting standard laboratory mice with the hepatitis E virus fails because the pathogen cannot successfully attach to or enter murine liver cells. According to data from the National Institutes of Health, viral host range is heavily dictated by surface receptors on host cells and intracellular replication factors. When hepatitis E encounters murine cellular membranes, it lacks the precise structural keys required to unlock entry into the cell, stopping the infection cycle before replication can begin.
Implications for Hepatitis E Research
Researchers studying hepatitis E rely heavily on animal models to test antiviral drugs and vaccines safely before human clinical trials. Because mice possess intrinsic genetic barriers against the virus, scientists must use specialized humanized mouse models or alternative animal models, such as pigs or non-human primates, which naturally support viral replication. According to the Centers for Disease Control and Prevention, identifying these host restriction factors is essential for developing reliable preclinical testing frameworks that accurately mimic human infection dynamics.
Frequently Asked Questions
Can humans catch hepatitis E from mice?
No documented cases show humans contracting hepatitis E from mice, primarily because the virus cannot replicate inside murine hosts. Transmission to humans typically occurs through consuming undercooked pork or contaminated water, according to World Health Organization guidelines.
Why are animal models important for virology?
Animal models allow researchers to observe disease progression, immune responses, and treatment efficacy in a living organism before testing therapies on human volunteers.